Your browser doesn't support javascript.
loading
The impact of cytoreductive nephrectomy on survival outcomes in patients treated with tyrosine kinase inhibitors for metastatic renal cell carcinoma in a real-world cohort.
Janisch, Florian; Hillemacher, Tobias; Fuehner, Constantin; D'Andrea, David; Meyer, Christian P; Klotzbücher, Thomas; Kienapfel, Christina; Vetterlein, Malte W; Kimura, Shoji; Abufaraj, Mohammad; Dahlem, Roland; Shariat, Shahrokh F; Fisch, Margit; Rink, Michael.
Afiliação
  • Janisch F; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Hillemacher T; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Fuehner C; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • D'Andrea D; Department of Urology, Medical University of Vienna, Vienna, Austria.
  • Meyer CP; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Klotzbücher T; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kienapfel C; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Vetterlein MW; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Kimura S; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Urology, Jikei University School of Medicine, Tokyo, Japan.
  • Abufaraj M; Department of Urology, Medical University of Vienna, Vienna, Austria; Department of Special Surgery, Jordan University hospital, The University of Jordan, Amman, Jordan.
  • Dahlem R; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Shariat SF; Department of Urology, Medical University of Vienna, Vienna, Austria; Institute for Urology and Reproductive Health, Sechenov University, Moscow, Russia; Department of Urology, Weill Cornell Medical School, New York, NY; Department of Urology, University of Texas Southwestern Medical Center, Dallas,
  • Fisch M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: m.rink@uke.de.
Urol Oncol ; 38(9): 739.e9-739.e15, 2020 09.
Article em En | MEDLINE | ID: mdl-32576526
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Procedimentos Cirúrgicos de Citorredução / Sorafenibe / Sunitinibe / Neoplasias Renais / Nefrectomia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Carcinoma de Células Renais / Inibidores de Proteínas Quinases / Procedimentos Cirúrgicos de Citorredução / Sorafenibe / Sunitinibe / Neoplasias Renais / Nefrectomia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Urol Oncol Assunto da revista: NEOPLASIAS / UROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Áustria País de publicação: Estados Unidos